FDA Approved: BACLOFEN — Supplemental Application (Medcore LLC)

View source ↗

Summary

FDA approved Medcore LLC's supplemental application for Baclofen (ANDA 214099).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)